## Abstract This study investigated the protein kinase C (PKC) and matrix metalloproteinase‐2 (MMP‐2) in the development of deciduomata in pseudo‐pregnant and pregnant rats. The results showed that the expression of MMP‐2 was significantly increased from day 2 to day 5 in pseudo‐pregnancy and from
Activation of cartilage matrix metalloproteinases by activated protein C
✍ Scribed by Miriam T. Jackson; Margaret M. Smith; Susan M. Smith; Christopher J. Jackson; Meilang Xue; Christopher B. Little
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 604 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objective
To investigate the role of activated protein C (APC) in cartilage degradation.
Methods
Chondrocyte expression of protein C, endothelial protein C receptor (EPCR), and thrombomodulin (TM) were evaluated by reverse transcription–polymerase chain reaction (RT‐PCR). APC was immunolocalized in developing joints and in osteoarthritic (OA) cartilage from humans. The effect of APC on aggrecan and collagen degradation was examined in explant cultures of ovine cartilage in control cultures and in cultures stimulated with interleukin‐1α (IL‐1α), tumor necrosis factor α (TNFα), or retinoic acid (RetA), using colorimetric assays and Western blotting. Chondrocyte expression of matrix metalloproteinases (MMPs), ADAMTS, and tissue inhibitor of metalloproteinases (TIMPs) was measured by RT‐PCR. MMP‐2 and MMP‐9 activity was evaluated by gelatin zymography and MMP‐13 by fluorogenic assay.
Results
Positive cellular immunostaining for APC was found at sites of MMP activity in developing joints and in OA, but not normal, cartilage. Chondrocytes expressed messenger RNA for protein C, EPCR, and TM, with the latter 2 levels increased by IL‐1α and TNFα stimulation. APC augmented aggrecan release and initiated collagen breakdown in IL‐1α–treated and TNFα‐treated cartilage, but not in normal or in RetA‐treated cartilage. APC‐stimulated aggrecan and collagen breakdown were due to MMP activity but were not associated with modulation of MMP, ADAMTS, or TIMP expression. APC resulted in MMP‐13 activation in cartilage cultures. APC could not directly activate proMMP‐13, but it was associated with increased MMP‐2 and MMP‐9 activity.
Conclusion
APC may be a relevant activator of MMPs in cartilage and may play a role in progressive cartilage degradation in arthritis.
📜 SIMILAR VOLUMES
Objective. To determine whether matrix metalloproteinases (MMPs) degrade cartilage oligomeric matrix protein (COMP) to produce fragments similar to those found in synovial fluid (SF) from patients with arthritis. Methods. COMP fragments were generated in vitro by treating (a) bovine articular carti
Remodelling of extracellular matrix (ECM) and basement membranes is a key component of the process of tumour cell invasion and metastasis. Matrix metalloproteinases (MMPs) are one of the major classes of enzymes involved in degrading ECM, having different substrate specificities and being inhibited
## Abstract ## Objective We have previously reported the up‐regulation of matrix metalloproteinase 10 (MMP‐10) following treatment with the procatabolic stimulus of interleukin‐1 (IL‐1) and oncostatin M (OSM) in chondrocytes. Although MMP‐10 is closely related to MMP‐3, little is known about the r